3,4-DCMP | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Conformer structure via JSmol |
Physical properties [] | |
---|---|
Molecular mass | 302.2 g/mol [1] |
Predicted LogP | 1.5 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C14H17Cl2NO2 [1] |
IUPAC name | methyl 2-(3,4-dichlorophenyl)-2-piperidin-2-ylacetate [1] |
SMILES | COC(=O)C(C1CCCCN1)C2=CC(=C(C=C2)Cl)Cl [1] |
InChI | InChI=1S/C14H17Cl2NO2/c1-19-14(18)13(12-4-2-3-7-17-12)9-5-6-10(15)11(16)8-9/h5-6,8,12-13,17H,2-4,7H2,1H3 [1] |
InChIKey | JUKMAYKVHWKRKY-UHFFFAOYSA-N [1] |
3,4-Dichloromethylphenidate
3,4-Dichloromethylphenidate (also known as 3,4-CTMP HCl salt, KIA77665, 3,4-Dichloromethylphenidate, threo, racemic, Q4634059, (RS/SR)-methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate or methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate hydrochloride) is a
Stereochemistry []
3,4-Dichloromethylphenidate is a
Legal status
- Canada: 3,4-Dichloromethylphenidate is a Schedule III substance.
- Germany: 3,4-Dichloromethylphenidate is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: 3,4-Dichloromethylphenidate is a Class B substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 44418862, 3,4-Dichloromethylphenidate. Accessed July 4, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/44418862